Dataset Information

Metabolomics reveals molecular signatures for psoriasis biomarkers and drug targets discovery

ABSTRACT: Psoriasis is a chronic skin disease that affects multiple systems and can be influenced by immunological, environmental, and genetic factors. The discovery of plasma biomarkers of psoriasis and the regulation of metabolic pathways helps us understand psoriasis and may assist clinicians in the diagnosis and treatment of psoriasis. Here, we used untargeted metabolomics based on high-resolution liquid chromatography-mass spectrometry to study the changes of metabolites and metabolic pathways in plasma samples of psoriasis. A total of 301 differential metabolites were detected, of which 10 metabolites were possible potential biomarkers, including vitamins, amino acids and lipids. At the same time, KEGG pathway enrichment analysis was performed on all the detected differential metabolites, and it was found that protein digestion and absorption, amino acid metabolism and lipid metabolism may jointly participate in the regulation of pathogenesis of psoriasis. In addition, three proteins ESR1, OPRM1 and HSD11B1 were identified as possible potential topical therapeutic targets for psoriasis by metabolite-protein interaction network analysis. In this study, plasma metabolites were characterized in patients with psoriasis which provided a new understanding of the role of metabolites in psoriasis. It also deepened the understanding of the pathogenesis of psoriasis and proposed new ideas and methods for the auxiliary diagnosis and treatment of the disease.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse phase, Liquid Chromatography MS - positive - reverse phase

PROVIDER: MTBLS5185 | MetaboLights | 2024-09-26

REPOSITORIES: MetaboLights

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 470

Publications

Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery.

Song Qian Q Chen Ying Y Ma JianQing J Zhou Wei W Song JunYan J Wu ChunFu C Liu Jie J

Clinical, cosmetic and investigational dermatology 20231104

<h4>Purpose</h4>Psoriasis is a chronic, multi-system skin disease that can be influenced by immunological, environmental, and genetic factors. Plasma metabolomic analysis can provide a great deal of information on potential diagnostic biomarkers, pathogenesis and personalized treatment. However, the role of metabolites in psoriasis is unknown.<h4>Patients and methods</h4>We performed an untargeted metabolomic analysis of plasma based on high-resolution liquid chromatography mass spectrometry fro ...[more]

PMID: 37941849

Similar Datasets

Project description:Background MicroRNAs are important regulators of transcription in hematopoiesis. Their expression deregulations were described in association with pathogenesis of some hematological malignancies. This study provides integrated microRNA expression profiling at different phases of chronic myeloid leukemia (CML) with the aim to select CML specific miRNAs and find new possible biomarkers. The functions of in silico filtered targets are in this report annotated and discussed in relation to CML pathogenesis. Results Using microarrays we identified differential expression profiles of 49 miRNAs in CML patients at diagnosis, in hematological relapse, therapy failure, blast crisis and major molecular response. The expression deregulation of miR-150, miR-20a, miR-17, miR-19a, miR-103, miR-144, miR-155, miR-181a, miR-221 and miR-222 in CML was confirmed by real-time quantitative PCR and in silico analyses identified targeted genes of these miRNAs encoding proteins that are involved in cell cycle, growth inhibition, MAPK, ErBb, transforming growth factor beta and p53 signaling pathways that are related to CML. Validated miR-150 decreased levels were detected in patients at diagnosis, in blast crisis and 67% of hematological relapses and showed significant negative correlation with miR-150 proved target MYB and with BCR-ABL transcript level. Conclusions This study revealed microRNAs that may be related to the CML pathogenesis and may reflect transformation from chronic to accelerated phases. The obtained expression patterns in peripheral blood total leukocytes during the course of CML suggest specific miRNAs as possible biomarkers. The annotated functions of in silico filtered targets of selected miRNAs outline mechanisms whereby microRNAs may be involved in CML pathogenesis. Twenty four patient samples of total leukocytes from peripheral blood were used to prepare pools representing different CML phases for microarray analysis: diagnosis (n=5, Dg), major molecular response (n=5, MMR), therapy failure (n=5, TF), hematological relapse (n=5, Hr), and blast crisis (n=4, BC). Eleven healthy donors of age median 60 (range 45 - 78) and man/woman ratio 3/2 following CML incidence were used to create a control pool.

			Action	DRS
	_CHRO001.DAT	Other
	_FUNC001.DAT	Other
	_FUNC002.DAT	Other
	_FUNC003.DAT	Other
	_CHRO001.DAT	Other